{
    "title": "110_hr3023",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Drug and Medical Device Company Gift \nDisclosure Act''.\n\nSEC. 2. DISCLOSURE OF CERTAIN GIFTS BY MANUFACTURERS, PACKERS, AND \n              DISTRIBUTORS OF PRESCRIPTION DRUGS AND MEDICAL DEVICES.\n\n    Section 503 of the Federal Food, Drug, and Cosmetics Act (21 U.S.C. \n353) is amended by adding at the end the following:\n    ``(h)(1) Each manufacturer, packer, or distributor of a drug \nsubject to subsection (b)(1) or of a device shall disclose to the \nCommissioner--\n            ``(A) not later than June 30, 2007, and each June 30 \n        thereafter, the value, nature, and purpose of any--\n                    ``(i) gift provided, directly or indirectly, during \n                the preceding calendar year to any covered health \n                entity by the manufacturer, packer, or distributor, or \n                a representative or agent thereof, in connection with \n                detailing, promotional, or other marketing activities; \n                and\n                    ``(ii) cash rebate, discount, or any other \n                financial consideration provided during the preceding \n                calendar year to any pharmaceutical benefit manager by \n                the manufacturer, packer, or distributor, or a \n                representative or agent thereof, in connection with \n                detailing, promotional, or other marketing activities; \n                and\n            ``(B) not later than the date that is 6 months after the \n        date of enactment of this subsection and each June 30 \n        thereafter, the name and address of the individual responsible \n        for the compliance of the manufacturer, packer, or distributor \n        with the provisions of this subsection.\n    ``(2) Each disclosure under this subsection shall be made in such \nform and manner as the Commissioner may require.\n    ``(3) For purposes of this subsection:\n            ``(A) The term `covered health entity' includes, but is not \n        limited to, any physician, nurse, therapist, hospital, nursing \n        home, pharmacist, health benefit plan administrator, or any \n        other person authorized to prescribe or dispense drugs that are \n        subject to subsection (b)(1), in the District of Columbia or \n        any State, commonwealth, possession, or territory of the United \n        States. Such term includes an individual who is not directly \n        employed by the drug or device manufacturer, packer, \n        distributor, representative, or agent.\n            ``(B) The term `gift' includes any gift, fee, payment, \n        subsidy, amenity, object, service or other economic benefit, \n        except that such term excludes the following:\n                    ``(i) Free samples of drugs subject to subsection \n                (b)(1) intended to be distributed to patients free of \n                charge.\n                    ``(ii) The payment of reasonable compensation and \n                reimbursement of expenses in connection with any bona \n                fide clinical trial conducted in connection with a \n                research study designed to answer specific questions \n                about drugs, devices, new therapies, or new ways of \n                using known treatments.\n                    ``(iii) Any scholarship or other support for \n                medical students, residents, or fellows selected by a \n                national, regional, or specialty medical or other \n                professional association to attend a significant \n                educational, scientific, or policy-making conference of \n                the association.\n    ``(4) With respect to gifts, paragraph (1) shall only apply if the \ntotal value of any gift or gifts provided during the applicable \ncalendar year is fifty dollars or more.\n    ``(5) Subject to paragraph (6), the Commissioner shall make all \ninformation disclosed to the Commissioner under paragraph (1) publicly \navailable, including by posting such information on the Internet.\n    ``(6) The Commissioner shall keep confidential any information \ndisclosed to or otherwise obtained by the Commissioner under this \nsubsection that relates to a trade secret referred to in section 1905 \nof title 18, United States Code. The Commissioner shall provide an \nopportunity in the disclosure form required under paragraph (2) for a \nmanufacturer, packer, or distributor to identify any such information.\n    ``(7) Each manufacturer, packer, or distributor described in \nparagraph (1) shall be subject to a civil monetary penalty of not more \nthan $10,000 for each violation of this subsection. Each unlawful \nfailure to disclose shall constitute a separate violation. The \nprovisions of paragraphs (3), (4), and (5) of section 303(f) shall \napply to such a violation in the same manner as such provisions apply \nto a violation of a requirement of this Act that relates to devices.\n    ``(8)(A) The Commissioner shall have authority to investigate \ncompliance with this subsection.\n    ``(B) If, after carrying out an investigation under this paragraph, \nthe Commissioner has reasonable cause to believe that a report required \nunder this subsection has not been filed in accordance with the \nprovisions of this section, the Commissioner may petition the United \nStates District Court in which the responsible party resides or \ntransacts business, for an order requiring submission of a report and \nsuch other relief as the Court considers appropriate.''."
}